|
1. FDA panel recommends easing restrictions on 6 of 7 peptides: What to know Full story
2. Where the GLP-1 compounding fight stands: 5 things to know Full story
3. How RWJBarnabas, Advocate and Corewell are rethinking cardiovascular care transitions, here.
4. FDA releases 17 peptide drug guidances Full story
5. 6 GLP-1 findings to know Full story
6. Lengthy patient boarding? See how University Health extended its EHR to break the cycle — here.
7. FDA approves 1st Tylenol pain relief combination Full story
8. Thyroid medication recalled nationwide Full story
Becker’s Learning Opportunities
9. New report: Where rare cardiac disease pathways break down — and how to bridge them — here.
10. Cancer care no longer fits inside hospital walls. Oncology leaders share what’s next, here.
11. Is ‘decision debt’ eroding your margin? Find out here.
12. Becker’s resources don’t stop here — explore more webinars and whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
